Hypertension Epidemiology and Economic Burden: Refining Risk Assessment To Lower Costs
More like this
- Clinical and Economic Effects of Coronary Restenosis After Percutaneous Coronary Intervention in a Managed Care Population
- How Does Management of Echocardiography Affect Use Across Risk Groups?
- Will Biomarkers Bring Smarter Care?
- Will Biomarkers Be Next Leap Forward in RA?
- Insurers skeptical of usefulness of companion diagnostics